期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

艾拉莫德致肝损害1例及其相关文献复习 被引量：1

下载PDF
导出
摘要 类风湿关节炎（rheumatoid arthritis,RA）是一种以侵蚀性关节炎为主要表现的全身性自身免疫性疾病,临床一般使用慢作用抗风湿药进行常规治疗。艾拉莫德是一种新型慢作用抗风湿药,临床发现可引起可逆性肝脏酶升高。本院近来使用艾拉莫德治疗RA引起肝损害1例,并复习艾拉莫德作用机制的相关文献,望引起临床医生的重视,现报道如下。
作者 刘维 孙淳 吴沅皞
机构地区 天津中医药大学第一附属医院 天津中医药大学
出处 《风湿病与关节炎》 2015年第2期44-45,47,共3页 Rheumatism and Arthritis
基金 国家自然科学基金面上项目(81273709) 天津市高等学校科技发展基金计划(20120220)
关键词 关节炎 类风湿 艾拉莫德 肝损害 不良反应
分类号 R575 [医药卫生—消化系统]
  • 相关文献

参考文献12

  • 1Riendeau D,Charleson S,Cromlish W,et al.Comparison of the cyclooxygenase-1 inhibitory properties of non- steroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors,using sensitive microsomal and platelet assays [J] .Can J of Physiol Pharma- co1,1997,75 ( 9 ) :1088-1095.
  • 2Tanaka K,Makino S,Shirnotori T,et al.Pharmacological studies of the new antiinflammatory agent 3-formylami- no-7-methylsulfonylamino-6-phenoxy-4' -1-benzopy- ran-4-one.2nd communication:effect on the arachidonic acid cascades[J ] .Arzneimittel-Forschung,1992,42 (7) :945-950.
  • 3Du F,Lti L,Fu Q,et al.T-614,a novel immunomodula- tor,attenuates joint inflammation and articular dam- age in collagen-induced arthritis [J].Arthritis Res Ther,2008,10 ( 6 ) :R136.
  • 4Tanaka K,Yamamoto T,Aikawa Y,et al.Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice [ J ] .Rheumatology (Oxford) ,2003,42 ( 11 ) :1365-1371.
  • 5Kohno M,Aikawa Y, Tsubouchi Y, et al.Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cyto- kine production and nuclear factor-kappaB activation in cultured human synovial cells[J] .J Rheuma- tol,2001,28 (12) :2591-2596.
  • 6Kawakami A,Tsuboi M,Urayama S,et al.Inhibitory effect of a new anti-rheumatic drug T-614 on costim- ulatory molecule expression,cytokine production,and antigen presentation by synovial cells [ J ] .J Lab Clin Med,1999,133 ( 6 ) :566-574.
  • 7孙晓萱,甘晓霞,谈文峰,魏禺,华敏慧,张缪佳.新型抗风湿药艾拉莫德抑制Th17细胞分化的调节作用[J].现代免疫学,2013,33(5):365-369. 被引量：7
  • 8Du F,Lti LJ,Teng JL,et al.T-614 alters the production of matrix metalloproteinases ( MMP-1 and MMP-3 ) and inhibits the migratory expansion of rheumatoid synovial fibroblasts,in vitro [J] .Int Immunopharmacol,2012,13 ( 1 ) :54-60.
  • 9Kuriyama K,Higuchi C,Tanaka K,et al.A novel an- ti-rheumatic drug, T-614,stimulates osteoblastic differ- entiation in vitro and bone morphogenetic protein-2-in- duced bone formation in vivo [ J ] .Biochem Biophys Res Commun,2002,299 ( 5 ) :903-909.
  • 10李秋霞,古洁若.艾拉莫德对小鼠成纤维细胞分泌胶原的影响[J].医学研究杂志,2009,38(10):44-47. 被引量：4

二级参考文献37

  • 1舒强,李兴福,侯怀水,李栋,刘花香.艾拉莫德对骨关节炎滑膜成纤维样细胞特性的影响[J].中华风湿病学杂志,2006,10(7):389-392. 被引量：17
  • 2舒强,李兴福,刘花香,李栋.类风湿关节炎滑膜成纤维样细胞增殖特性的体外研究[J].山东大学学报（医学版）,2006,44(11):1095-1099. 被引量：7
  • 3Aikawa Y, Tanuma N, Shin T,et al. A new anti- rheumatic drug, T - 614, effectively suppresses the development of autoimmune encephalomyelitis. J Neuroimmunol, 1998,89 ( 1 - 2) :35 - 42.
  • 4Tanaka K, Yamamoto T, Aikawa Y,et al. Inhibitory effects of an anti - rheumatic agent T -614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice. Rheumatology (Oxford) ,2003 ,42( 11 ) :1365 - 1371.
  • 5Futaki N, Yoshikawa K, Hamasaka Y,et al. NS -398, a novel non - steroidal anti - inflammatory drug with potent analgesic and antipyretie effects, which causes minimal stomach lesions. Gen Pharmaeol, 1993, 24(1) :105 -110.
  • 6Zamoiskii EA. Evaluation of Reed - Muench method in determination of activity of biological preparations. Zh Mikrobiol Epidemiol Immunohiol, 1956,27 ( 1 ) :77 - 83.
  • 7Leighton J, Estes LW, Goldblatt PJ, et al. The formation of histotypic fibrous collagen in matrix tissue culture by 3T6 mouse fibroblasts: a response to ascorbic acid. In Vitro,1970 ,6 (3) : 153 - 161.
  • 8Lories RJ, Derese I, De Bari C ,et al. In vitro growth rate of fibroblast - like synovial cells is reduced by methotrexate treatment. Ann Rheum Dis,2003,62(6) :568 - 571.
  • 9Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology(Oxford), 2005, 44: 7-16.
  • 10Fiorito S, Magrini L, Adrey J, et al. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. Rheumatology (Oxford),2005, 44: 164-171.

共引文献1343

同被引文献26

  • 1菲尔斯坦.凯利风湿病学[M].粟占国,译.8版.北京:北京大学医学出版社.2011:1089.
  • 2Tukowi J,Chlatdek J,Hroch M,et al.677TT genotype is associated with elevated risk ofmethotrexate ( MTX ) toxicity in juvenile idiopathic arthritis:treatment outcome,erythrocyte concentrations of MTX and fo-lates,and MTHFR polymorphisms [ J ] .J Rheumatol, 2010,37 (10) :2180-2186.
  • 3Nishimoto N,Hashimoto J, Miyasaka N.Study of active controlled monotherapy used for rheumatoid arthritis,an IL-6 inhibitor ( SAMURAI ) :evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlld trial of tocilizumab [J].Ann Rheum Dis,2007,66 ( 9 ) :1162-1167.
  • 4Cutolo M,Sulli A,Pizzorni C,et al.Anti-inflammatory mecha-nisms of methotrexate in rheumatoid arthritis[ J ]. Ann Rheum Dis,2001,60 ( 8 ) :729-735.
  • 5Tian H,Cronstein BN.Understanding the mechanism of action of methotrexate:implications for the treat- ment of rheumatoid arthritis [ J ] .Bull NYU Hosp Jt Dis,2007,65 ( 3 ) :168-173.
  • 6Luo Q,Sun Y,Liu W,et al.A Novel Disease-Modifying Antirheumatic Drug,Iguratimod,Ameliorates Mu- rine Arthritis by Blocking IL-17 Signaling,DIStinct from Methotrexate and Leflunomide [ J ] .J Immu- nol,2013,191 (10) :4969-4978.
  • 7Singh JA,Furst DE,Bharat A,et al.2012 update of the 2008 American College of Rheumatology recommen- dations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheuma- toid arthritis [ J ].Arthritis Care Res( Hoboken ),2012,64 ( 5 ) :625-639.
  • 8Smolen JS,Landewe R,Breedveld FC,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modify- ing antirheumatic drugs:2013 update [ J ] .Ann Rheum Dis,2014, 73 ( 3 ) :492-509.
  • 9Genestier L,Paillot R, Foumel S,et al.Immunosuppres- sive properties of methotrexate:apoptosis and clonal deletion of activated peripheral T cells [ J ] .J Clin In- vestig,1998,102 ( 2 ) :322-328.
  • 10May M.IL-17R signaling:new players get in on the Actl [J].Nature Immunology,2011,12 ( 9 ):813-815.

引证文献1

二级引证文献13

风湿病与关节炎
2015年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部